Twilight Venture Partners

Twilight Venture Partners is a venture capital firm dedicated to fostering early-stage life science companies, driving breakthroughs in biotechnology and medical technology with a strategic focus on the dynamic Asian market. The firm invests exclusively in early-stage biotech and med tech companies, leveraging the extensive experience of its partners to select outstanding companies and provide guidance to their management teams. With a deep understanding of the biotechnology and medical technology sectors, Twilight Venture Partners seeks out innovations with the potential for significant impact, particularly within the burgeoning Asian market. The firm's approach goes beyond simply providing funding; it strives to be a true partner to the companies it invests in, offering deep industry knowledge, an extensive network, and strategic insights to help them navigate the complexities of early-stage development and achieve their full potential. Twilight Venture Partners is committed to partnering with companies that are poised to reshape healthcare and improve lives, providing not just capital but also strategic guidance and a global network to help visionary entrepreneurs bring their innovations to life. The firm's team brings together a wealth of experience in life sciences, venture capital, and global business, passionate about supporting early-stage companies and leveraging their collective expertise to help them succeed. The partners have collectively more than 150 years of life science industry experience and have worked together for more than 25 years, creating billions of dollars in value for investors while bringing vital products to market that improved clinical outcomes and saved patient lives. The team consists of former executives from the Pharmaceutical and Medical Device industry, including founders of Guidant Corporation, and is committed to maintaining the highest standards of integrity. Twilight Venture Partners is always eager to connect with visionary entrepreneurs, fellow investors, and industry leaders who share a passion for advancing life sciences. The firm encourages early-stage life science companies with groundbreaking potential, as well as potential partners, to reach out and explore opportunities for collaboration.